Arterial hypertension and stroke prevention: an update

Area of Science:

• Cardiovascular Medicine
• Neurology
• Pharmacology

Background:

• High blood pressure (BP) is a primary modifiable risk factor for stroke and vascular diseases.
• Antihypertensive medications are proven effective in stroke prevention through randomized controlled trials.
• Potential differences in drug class effects and actions in patient subgroups warrant further investigation.

Purpose of the Study:

• To review the evolution of antihypertensive therapies for arterial hypertension.
• To evaluate recent clinical trials concerning hypertension and stroke prevention.
• To identify unresolved questions for future research in stroke risk reduction.

Main Methods:

• Review of key randomized controlled trials: HOPE, ALLHAT, LIFE, and PROGRESS.
• Analysis of antihypertensive drug classes including ACE inhibitors, ARBs, CCBs, and diuretics.
• Evaluation of evidence on drug effects versus class effects in stroke prevention.

Main Results:

• Established evidence supports BP lowering for stroke prevention.
• Specific trials (HOPE, ALLHAT, LIFE, PROGRESS) provide data on various antihypertensive agents.
• Unresolved issues persist regarding optimal drug selection and use.

Conclusions:

• While BP reduction is key, specific drug effects versus class effects require clarification.
• Further research is needed to determine if Angiotensin II Receptor Blockers (ARBs) are superior to Angiotensin-Converting Enzyme Inhibitors (ACE-Is).
• The role of ACE-Is and ARBs in high-risk stroke patients and the impact of lifestyle interventions need further study.